Skip to main content

PET-Neuroimaging and Neuropsychological Study for Early Cognitive Impairment in Parkinson’s Disease

  • Conference paper
  • First Online:
Bioinformatics and Biomedical Engineering (IWBBIO 2022)

Part of the book series: Lecture Notes in Computer Science ((LNBI,volume 13346))

Abstract

To present time, the world science has accumulated a sufficient amount of information on the quantitative changes in the rate of glucose utilization according to positron emission tomography (PET) with 18-fluorodeoxyglucose (FDG) in Parkinson’s disease (PD) with dementia. It was found that in the early stages of dementia with PD, there is a dysfunction of the frontal lobes, while PET examination of patients with PD with dementia shows the quantitative changes in the rate of glucose utilization. On this basis, it seems relevant to compare the functional state of the brain structures and the results of neuropsychological studies in patients with PD with varying severity of cognitive impairment. The present research was aimed to investigate the relationship between early cognitive violations according to neuropsychological research and the rate of glucose metabolism in different brain areas during PET scanning in patients with Parkinson’s disease. Neuropsychological testing consisted of clinical interviews, observation, questioning, Mini-Mental State Exam (MMSE) and frontal assessment battery (FAB). According to the research outcomes, it was found that with initial cognitive impairment, determined by FAB, a quantitative change in the rate of glucose utilization is observed, similar to the pattern found in patients with cognitive disorders in PD. Four factors were established: factor 1 – dorsal system of attention (voluntary attention), factor 2 – ventral system of attention (involuntary attention), factor 3 – system of the state of operational rest, factor 4 – visual projective zone. The precentral cortex of the frontal areas and the upper half of the parietal zones of big brain are constitute the 1st factor. The anterior third of the convexital part of the frontal areas and the lower half of the parietal zones are the 2nd factor. The 3rd factor includes the 23, 36, 29 and 30 cytoarchitectonic Brodmann fields (the posterior cingulate gyrus). Primary visual area (17th Brodmann’s field) is the 4th factor.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Aarsland, D., Zaccai, J., Brayne, C.: A systematic review of prevalence studies of dementia in Parkinson’s disease. Mov. Disord. 20, 1255–1263 (2005)

    Article  Google Scholar 

  2. Bridges, R.L., Cho, C.S., Beck, M.R., Gessner, B.D., Tower, S.S.: F-18 FDG PET brain imaging in symptomatic arthroprosthetic cobaltism. Eur. J. Nucl. Med. Mol. Imaging 47(8), 1961–1970 (2019). https://doi.org/10.1007/s00259-019-04648-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Buchert, R., Buhmann, C., Apostolova, I., Meyer, P.T., Gallinat, J.: Nuclear imaging in the diagnosis of clinically uncertain parkinsonian syndromes. Dtsch. Arztebl. Int. 116, 747–754 (2019)

    PubMed  PubMed Central  Google Scholar 

  4. Campoy, A.-D.T., Liang, C., Ladwa, R.M., et al.: [18F] Nifene PET/CT imaging in mice: improved methods and preliminary studies of α4β2* nicotinic acetylcholinergic receptors in transgenic A53T mouse model of α-synucleinopathy and post-mortem human Parkinson’s disease. Molecules 26, 7360 (2021)

    Article  CAS  Google Scholar 

  5. Cohen, O.S., Vakil, E., Tanne, D., et al.: The frontal assessment battery as a tool for evaluation of frontal lobe dysfunction in patients with Parkinson disease. J. Geriatr. Psychiatry Neurol. 2, 71–77 (2012)

    Article  Google Scholar 

  6. Ferri, C.P., Prince, M., Brayne, C., et al.: Global prevalence of dementia: a Delphi consensus study. Lancet 366, 2112–2117 (2005)

    Article  Google Scholar 

  7. Folstein, M.F., Folstein, S.E., McHugh, P.R.: Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J. Psychiatric Res. 2, 189–198 (1975)

    Article  Google Scholar 

  8. Fujimi, K., Sasaki, K., Noda, K., et al.: Clinicopathological outline of dementia with Lewy bodies applying the revised criteria: the Hisayama study. Brain Pathol. (Zurich, Switzerland). 18, 317–325 (2008)

    Article  Google Scholar 

  9. Gan, J., Liu, S., Wang, X., et al.: Clinical characteristics of Lewy body dementia in Chinese memory clinics. BMC Neurol. 21, 144 (2021)

    Article  Google Scholar 

  10. Hely, M.A., Morris, J.G., Reid, W.G.: Sydney multicenter study of Parkinson’s disease: non-L-dopa-responsive problems dominate at 15 years. Mov. Disord. 3, 190–199 (2005)

    Article  Google Scholar 

  11. Kane, J.P.M., Surendranathan, A., Bentley, A., et al.: Clinical prevalence of Lewy body dementia. Alz. Res. Ther. 10, 19 (2018). https://doi.org/10.1186/s13195-018-0350-6

    Article  Google Scholar 

  12. Khil’ko, V., Shostak, V., Khlunovskiǐ, A., et al.: The topographic mapping of evoked bioelectrical activity and other methods for the functional neural visualization of the brain. Vestn. Ross. Akad. Med. Nauk 3, 36–41 (1993)

    Google Scholar 

  13. Leh, S.E., Petrides, M., Strafella, A.P.: The neural circuitry of executive functions in healthy subjects and Parkinson’s disease. Neuropsychopharmacology 1, 70–85 (2010)

    Article  Google Scholar 

  14. Loane, C., Politis, M.: Positron emission tomography neuroimaging in Parkinson’s disease. Am. J. Transl. Res. 3, 323–341 (2011)

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Lytaev, S.A., Susin, D.S.: PET-diagnostics of cognitive impairment in patients with Parkinson’s disease. Pediatrician 7, 63–68 (2016)

    Google Scholar 

  16. Lytaev, S., Aleksandrov, M., Popovich, T., Lytaev, M.: Auditory evoked potentials and PET-scan: early and late mechanisms of selective attention. Adv. Intell. Syst. Comput. 775, 169–178 (2019)

    Google Scholar 

  17. Lytaev, S.: Modern neurophysiological research of the human brain in clinic and psychophysiology. In: Rojas, I., Castillo-Secilla, D., Herrera, L.J., Pomares, H. (eds.) BIOMESIP 2021. LNCS, vol. 12940, pp. 231–241. Springer, Cham (2021). https://doi.org/10.1007/978-3-030-88163-4_21

    Chapter  Google Scholar 

  18. Lytaev, S.: Modeling and estimation of physiological, psychological and sensory indicators for working capacity. Adv. Intell. Syst. Comput. 1201, 207–213 (2021)

    Google Scholar 

  19. Lytaev, S.: Long-latency event-related potentials (300–1000 ms) of the visual insight. Sensors 22, 1323 (2022)

    Article  Google Scholar 

  20. Murray, P.S., Kumar, S., Demichele-Sweet, M.A., Sweet, R.A.: Psychosis in Alzheimer’s disease. Biol. Psychiatry 75, 542–552 (2014)

    Article  Google Scholar 

  21. Palmqvist, S., Hansson, O., Minthon, L., Londos, E.: Practical suggestions on how to differentiate dementia with Lewy bodies from Alzheimer’s disease with common cognitive tests. Int. J. Geriatr. Psychiatry 24, 1405–1412 (2009)

    Article  Google Scholar 

  22. Poston, K.L., Eidelberg, D.: FDG PET in the evaluation of Parkinson’s disease. PET Clin. 1, 55–64 (2010)

    Article  Google Scholar 

  23. Silverman, D.H.S., Mosconi, L., Ercoli, L., et al.: PET scans obtained for evaluation of cognitive dysfunction. Semin. Nucl. Med. 38, 251–261 (2008)

    Article  Google Scholar 

  24. Surendranathan, A., Kane, J.P.M., Bentley, A., et al.: Clinical diagnosis of Lewy body dementia. BJPsych Open 6, e61 (2020)

    Article  Google Scholar 

  25. Szeto, J.Y.Y., Walton, C.C., Rizos, A., et al.: Dementia in long-term Parkinson’s disease patients: a multicentre retrospective study. NPJ Parkinson’s Dis. 6, 2 (2020)

    Article  Google Scholar 

  26. Talairach, J., Tournoux, P.: Co-planar stereotactic atlas of the human brain. In: 3-Dimensional Proportional System: An Approach to Cerebral Imaging, pp. 5–15. Thieme, New York (1988)

    Google Scholar 

  27. Taylor, J.P., McKeith, I.G., Burn, D.J., et al.: New evidence on the management of Lewy body dementia. Lancet Neurol. 19, 157–169 (2020)

    Article  Google Scholar 

  28. Thompson, E., Marrett, C., et al.: Performance evaluation of the PC-2048: a new 15-slice encoded-crystal PET scanner for neurological studies. IEEE Trans. Med. Imaging 2, 90–95 (1991)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sergey Lytaev .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this paper

Check for updates. Verify currency and authenticity via CrossMark

Cite this paper

Lytaev, S. (2022). PET-Neuroimaging and Neuropsychological Study for Early Cognitive Impairment in Parkinson’s Disease. In: Rojas, I., Valenzuela, O., Rojas, F., Herrera, L.J., Ortuño, F. (eds) Bioinformatics and Biomedical Engineering. IWBBIO 2022. Lecture Notes in Computer Science(), vol 13346. Springer, Cham. https://doi.org/10.1007/978-3-031-07704-3_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-07704-3_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-07703-6

  • Online ISBN: 978-3-031-07704-3

  • eBook Packages: Computer ScienceComputer Science (R0)

Publish with us

Policies and ethics